Clickable” Albumin Binders for Modulating the Tumor Uptake of Targeted Radiopharmaceuticals | Journal of Medicinal Chemistry
Genetically-Encoded Discovery of Perfluoroaryl-Macrocycles that Bind to Albumin and Exhibit Extended Circulation in-vivo
Exploring the Influence of Different Albumin Binders on Molecular Imaging Probe Distribution | Molecular Pharmaceutics
The Effect of Albumin-Binding Moiety on Tumor Targeting and Biodistribution Properties of 67Ga-Labeled Albumin Binder-Conjugated Alpha-Melanocyte-Stimulating Hormone Peptides | Cancer Biotherapy and Radiopharmaceuticals
Acylated heptapeptide binds albumin with high affinity and application as tag furnishes long-acting peptides | Nature Communications
Chemical Strategies for Half-Life Extension of Biopharmaceuticals: Lipidation and Its Alternatives | ACS Medicinal Chemistry Letters
177Lu-Labeled Albumin-Binder–Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio | Journal of Nuclear Medicine
Albumin binding Nanofitins, a new scaffold to extend half-life of biologics – a case study with exenatide peptide - ScienceDirect
Lymphatic targeting by albumin-hitchhiking: Applications and optimisation - ScienceDirect
Structure–Activity Relationships and Pharmacokinetics of 111In-Labeled Glucagon-like Peptide-1 Receptor-Targeting Exendin-4 Derivatives Conjugated with Albumin Binder Moieties | Molecular Pharmaceutics
Clickable” Albumin Binders for Modulating the Tumor Uptake of Targeted Radiopharmaceuticals | Journal of Medicinal Chemistry
A 177Lu-labeled albumin-binder-conjugated PSMA-617 derivative with greatly enhanced radiation dose delivered to LNCaP tumor xenografts | Journal of Nuclear Medicine
Bench to Bedside: Albumin Binders for Improved Cancer Radioligand Therapies | Bioconjugate Chemistry
177Lu-Labeled Albumin-Binder–Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio | Journal of Nuclear Medicine
Generation of therapeutic protein variants with the human serum albumin binding capacity via site-specific fatty acid conjugation | Scientific Reports
177Lu-Labeled Albumin-Binder–Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio | Journal of Nuclear Medicine
In Vivo Half-Life Extension of BMP1/TLL Metalloproteinase Inhibitors Using Small-Molecule Human Serum Albumin Binders - ScienceDirect
Feasibility of using a 99mTc-hydroxamamide complex containing an albumin binder moiety for in vivo albumin labeling-based tumor imaging,Bioorganic & Medicinal Chemistry Letters - X-MOL
Pharmaceuticals | Free Full-Text | New 55Co-labeled Albumin-Binding Folate Derivatives as Potential PET Agents for Folate Receptor Imaging
Chemical structures of non-albumin DOTA-(PEG28)2-A20FMDV2 (A),... | Download Scientific Diagram
Molecules | Free Full-Text | Preclinical Evaluation of a New Series of Albumin-Binding 177Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics
Exploring the Influence of Different Albumin Binders on Molecular Imaging Probe Distribution | Molecular Pharmaceutics
A Portable Albumin Binder from a DNA‐Encoded Chemical Library - Dumelin - 2008 - Angewandte Chemie - Wiley Online Library
Harnessing albumin as a carrier for cancer therapies | Semantic Scholar
Frontiers | How Different Albumin-Binders Drive Probe Distribution of Fluorescent RGD Mimetics
